title: [Treatment of venous thromboembolic disease in the elderly].
abstract: The incidence of deep vein thrombosis and pulmonary embolism is higher in the elderly due to the greater frequency of risk factors among this age group. Classic treatment with heparin and subsequently oral anticoagulant is still the most commonly used. Older patients may be at increased risk for anticoagulant-related bleeding for several reasons: increased anticoagulant effect of warfarin, increased prevalence of comorbidity and incidence of adverse drug reactions. As well as the usual contra-indications to such treatment, the psychological and physical well being of the patient must be assumed before an oral anticoagulant can be given. Careful prescribing is required: a low starting dose, a strict monitoring regime, for a limited duration. The indications for use of an inferior vena cava filter are wider in the older age group, not only for those in whom heparin is contraindicated, or has failed, but also for those who require treatment indefinitely with contra-indications to oral anticoagulant. Careful consideration of risk factors and the use of an individually designed prophylactic treatment are the best way to tackle this difficult problem in the elderly person.
authors.affiliation: Service de Médecine Interne A, CHU, Hôtel-Dieu, Nantes.
authors.forename: D
authors.initials: D
authors.lastname: el Kouri
authors.forename: P
authors.initials: P
authors.lastname: Chevalet
authors.forename: M
authors.initials: M
authors.lastname: Hamidou
authors.forename: J
authors.initials: J
authors.lastname: Lemant
authors.forename: G
authors.initials: G
authors.lastname: Potel
mesh_terms: D000368:Aged; D000925:Anticoagulants / Q000627:therapeutic use; D003131:Combined Modality Therapy; D005602:France / Q000453:epidemiology; D006493:Heparin / Q000627:therapeutic use; D006801:Humans; D011655:Pulmonary Embolism / Q000453:epidemiology / Q000517:prevention & control / Q000628:therapy*; D012307:Risk Factors; D020246:Venous Thrombosis / Q000453:epidemiology / Q000517:prevention & control / Q000628:therapy*
chemical_list: D000925:Anticoagulants; D006493:Heparin